-
Awarded04/11/2024
-
Today08/12/2024
Utilities
- indicates text translated automatically in your browsing language
Supply of exclusive medicines: Darbepoetin alfa (ARANESP), Evolocumab (REPATHA), Etelcalcetide (PARSABIV) and Filgrastim (NEUPOGEN vial). Text automatically translated in your browsing language Automatically translated
Supply of exclusive medicines: Darbepoetin alfa (ARANESP), Evolocumab (REPATHA), Etelcalcetide (PARSABIV) and Filgrastim (NEUPOGEN vial). Text automatically translated in your browsing language Automatically translated
Type: cost
Description: Coste
Weight (percentage, exact): 100
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.